The Biden administration is expected to release the next batch of drugs that will be subject to Medicare price negotiations — ...

Starting Ozempic or Wegovy can feel overwhelming, and many patients make critical mistakes that could affect their results.

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?